Rare side effects include nausea or gastrointestinal upset (usually methionine-related at high doses), allergic reactions to B12 (cyanocobalamin), or transient mood changes during methylation pathway adjustments
QR-110, an ASO drug in Phase III trials, was designed to address Leber congenital amaurosis type 10 caused by the p.Cys998X mutation in the centrosomal protein 290 gene
Ozempic (Semaglutide)
GLUTATHIONE AND COVID-19 Endogenous glutathione deficiency worsens oxidative lung damage caused by SARS-CoV-2, leading to severe symptoms such as acute respiratory distress syndrome, multiple organ failure, and death
The herbal wellness patch category lacks clinical trial evidence
Restraining Factors The United States semaglutide market faces obstacles like the competing high treatment costs pose significant financial hurdles, especially for uninsured populations with limited resources